Human Cartilage Acidic Protein 1 (CRTAC1) ELISA Kit from MyBioSource.com

Supplier Page

Supplier Page from
MyBioSource.com for
Human Cartilage Acidic Protein 1 (CRTAC1) ELISA Kit

Get Pricing

Description

This Human Cartilage Acidic Protein 1 (CRTAC1) ELISA Kit is intended for quantitative detection of human CRTAC1 in cell culture supernates, serum and plasma (heparin, EDTA, citrate). Strip well format. Reagents for up to 96 tests.
This human CRTAC1 ELISA Kit is based on standard sandwich enzyme-linked immune-sorbent assay technology. A monoclonal antibody from mouse specific for CRTAC1 has been precoated onto 96-well plates. Standards (Expression system for standard: NSO, Immunogen sequence: S28-C661) and test samples are added to the wells, a biotinylated detection polyclonal antibody from goat specific for CRTAC1 is added subsequently and then followed by washing with PBS or TBS buffer. Avidin-Biotin-Peroxidase Complex is added and unbound conjugates are washed away with PBS or TBS buffer. HRP substrate TMB are used to visualize HRP enzymatic reaction. TMB is catalyzed by HRP to produce a blue color product that changed into yellow after adding acidic stop solution. The density of yellow is proportional to the human CRTAC1 amount of sample captured in plate.
The capture antibody is a monoclonal antibody from mouse, the detection antibody is a biotinylated polyclonal antibody from goat. Expression system for standard: cartilage acidic protein 1 is a protein that in humans is encoded by the CRTAC1 gene. It is mapped to 10q24.2. This gene encodes a glycosylated extracellular matrix protein that is found in the interterritorial matrix of articular deep zone cartilage. This protein is used as a marker to distinguish chondrocytes from osteoblasts and mesenchymal stem cells in culture. The presence of FG-GAP motifs and an RGD integrin-binding motif suggests that this protein may be involved in cell-cell or cell-matrix interactions. Copy number alterations in this gene have been observed in neurofibromatosis type 1-associated glomus tumors. Alternative splicing results in multiple transcript variants